Skip to main content
. 2014 Sep 10;4:34–41. doi: 10.1016/j.rinphs.2014.09.001

Fig. 4.

Fig. 4

Plasma concentration-time profile of PM181104 following intravenous administration of formulations F1, F2, F3, F4 and F5 (2.5 mg kg−1) and F6, F7 and F8 (5.0 mg kg−1) to BALB/c mice. Data are mean±S.D., n = 3 mice.